DNADX

Solutions provider
in molecular diagnostics

+40

Employees including 20 molecular biology researchers

1

Manufacturing site in the Lyon region

ISO 13485:2016

Medical device quality standard

3

International hubs

A modular solution for every laboratory

DNADX, located in California, is at the heart of San Diego’s Biotech Beach, the third largest biotech center in America, behind San Francisco and Boston.

Our mission is to develop and market, in collaboration with our sister companies, molecular solutions, instruments, reagents and kits, targeting difficult diseases in the human, animal and plant diagnostics markets.

We’ll be exhibiting at the ADLM Clinical Lab Expo 2024 trade show and conference, to be held from July 28 to August 1, 2024 at the McCormick Place Convention Center in Chicago, Illinois.

Location: 1265

Une solution modulaire et personnalisable pour chaque laboratoire

Comprehensive care at the heart of the patient journey

Each product benefits from comprehensive support and offers a turnkey solution covering the entire patient journey, from data collection and analysis to post-diagnostic support.

pre-analytical phase

DNADX ensures optimal management right from the collection stage, providing sampling kits and rigorous protocols to preserve sample integrity.

Diagnostic analysis

Our devices enable analyses targeting pathogens, genetic mutations and clinical biomarkers, with consistent quality assurance.

post-analytical phase

After analysis, we transform the results into reports designed to be easily interpreted by healthcare professionals, facilitating clinical decisions.

Why choose DNADX?

An evolving product range

Our product range is constantly evolving to keep pace with advances in medical research. We rapidly integrate the latest advances to meet evolving healthcare needs.

A short production cycle

Thanks to our ability to synthesize oligonucleotides in-house, we significantly reduce the development cycle, ensuring rapid time-to-market and guaranteed continuous availability.

Adaptability for every market

Appolon Bioteck develops diagnostic solutions specifically designed for each market specificity. Our targeted approach ensures that each product complies with local regulatory standards.

+40 experts at the service of patient care

DNADX is a Said El Mouatassim (SEM) company, opened in 2021, to support research and development efforts, with its ability to tap into the vast scientific resources San Diego County offers, for the SEM group of companies, which includes Appolon Bioteck, in Lyon, France, Science Biomark, in Quebec, Canada, as well as others around the world. DNADX also supports the sales, marketing and distribution efforts of all SEM products and services in the United States.
Said El Mouatassim - Directeur général de DNADX

Said El Mouatassim

Managing Director, DNADX

40 experts au service du parcours patient

Any questions?

At DNADX, we understand the regulatory challenges faced by our French customers. We offer support in your accreditation process, including assistance in preparing the files needed to validate new techniques. Our approach is to provide local support, with flexibility and adaptability.

We are ISO 13485:2016 certified, demonstrating our commitment to the highest international standards for medical devices. What’s more, all our products are designed and manufactured in France, guaranteeing a high level of expertise and quality control.

We maintain a strategic buffer stock for all our distributed products, minimizing the risk of stock-outs. Should the need arise, our Lyon-based after-sales service is ready to react quickly to ensure your business continues uninterrupted.

Our logistics are optimized for rapid delivery throughout France and internationally. With efficient processes and a well-established distribution network, we ensure that your orders reach you in the shortest possible time.

Professionnels de la santé

Médecins de laboratoire, praticiens, pharmaciens, infirmiers, et autres professionnels directement impliqués dans la fourniture et l’interprétation de résultats de laboratoire.

Grand public

Patients et autres personnes qui ne sont pas directement impliquées dans la fourniture de prestations de santé.